Chemoinformaics analysis of Benzene, 1-methoxy-4-(1-methyl-2-propenyl)-
| Molecular Weight | 162.232 | nRot | 3 |
| Heavy Atom Molecular Weight | 148.12 | nRig | 7 |
| Exact Molecular Weight | 162.104 | nRing | 1 |
| Solubility: LogS | -4.013 | nHRing | 0 |
| Solubility: LogP | 3.547 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 28.5071 |
| nHD | 0 | BPOL | 15.7809 |
| QED | 0.621 |
| Synth | 2.417 |
| Natural Product Likeliness | 0.344 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.386 |
| MDCK | 0.000019 |
| BBB | 0.501 |
| PPB | 0.950417 |
| VDSS | 1.263 |
| FU | 0.0279462 |
| CYP1A2-inh | 0.938 |
| CYP1A2-sub | 0.959 |
| CYP2c19-inh | 0.911 |
| CYP2c19-sub | 0.875 |
| CYP2c9-inh | 0.534 |
| CYP2c9-sub | 0.872 |
| CYP2d6-inh | 0.68 |
| CYP2d6-sub | 0.923 |
| CYP3a4-inh | 0.777 |
| CYP3a4-sub | 0.598 |
| CL | 5.625 |
| T12 | 0.195 |
| hERG | 0.022 |
| Ames | 0.24 |
| ROA | 0.057 |
| SkinSen | 0.108 |
| Carcinogencity | 0.392 |
| EI | 0.916 |
| Respiratory | 0.086 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.771762 |